Role of increased production of monocytes TNF-α, IL-1β and IL-6 in psoriasis: Relation to focal infection, disease activity and responses to treatments

Journal of Dermatological Science

Volumn 14, Issue 2, 1997, Pages 145-153

  Mizutani, Hitoshi ^a   Ohmoto, Yasukazu ^b   Mizutani, Tomoko ^a   Murata, Minoru ^a   Shimizu, Masayuki ^a  

^a MIE UNIVERSITY   (Japan)

^b Otsuka Cellular Technology Institute   (Japan)

Author keywords

interleukin; methotrexate; psoriasis; tonsil; tumornecrosis factor

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INFECTION RISK; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROVOCATION TEST; PSORIASIS; RISK ASSESSMENT; SKIN DEFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; DERMATOLOGIC AGENTS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; KINETICS; MALE; METHOTREXATE; MIDDLE AGED; MONOCYTES; PSORIASIS; TONSIL; TONSILLECTOMY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031080905     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(96)00562-2     Document Type: Article

References (20)

1. [1] Groves RW, Sherman L, Mizutani H, Dower SK, Kupper TS: Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis. Am J Pathol 145: 1048-1056, 1994.
2. [2] Bonifati C, Carducci M, Cordiali Fei P, Trento E, Sacerdoti G, Fazio M, Ameglio F. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients-relationships with disease seventy. Clin Exp Dermatol 19: 383-387, 1994.
3. [3] Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Taylor RS, Voorhees JJ, Fisher G: Interleukin-1 in human skin: dysregulation in psoriasis. J Invest Dermatol 95: 24S-26S, 1990.
4. [4] Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Sauder DN, Voorhees JJ, Fisher G: IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol 144: 4593-4603, 1990.
5. [5] Gruaz D, Didierjean L, Grassi J, Frobert Y, Dayer JM, Saurat JH: Interleukin 1 alpha and beta in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoids. Dermatologica 179: 202-206, 1989.
6. [6] Kojima T, Cromie MA, Fisher GJ, Voorhees JJ, Elder JT: GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes. J Invest Dermatol 101: 767-772, 1993.
7. [7] Ohta Y, Katayama I, Funato T, Yokozeki H, Nishiyama S, Hirano T, Kishimoto T, Nishioka K: In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Arch Dermatol Res 283: 351-356, 1991.
8. [8] Prens EP, Benne K, van-Damme J, Bakkus M, Brakel K, Benner R, van-Joost T: Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol 95: 121S-124S, 1990.
9. [9] Gearing AJ, Fincham NJ, Bird CR, Wadhwa M, Meager A, Cartwright JE, Camp RD: Cytokines in skin lesions of psoriasis. Cytokine 2: 68-75, 1990.
10. [10] Gutzeit K, Parade G: Fokalinfektion. Erg Inn Med Kinderheilk 57: 613-722, 1939.
11. [11] Ohyanagi S, Kanamori M, Taniguchi Y, Shimizu M: [Generalized pustular psoriasis in siblings]. Nippon Hifuka Gakkai Zasshi 100: 1041-1045, 1990.
12. [12] Teranishi Y, Mizutani H, Murat M, Shimizu M, Matsushima K: Increased spontaneous production of IL-8 in peripheral blood monocytes from psoriatic patient: relation to focal infection and response to treatments. J Dermatol Sci 10: 8-15, 1995.
13. [13] Fredriksson T, Pettersson U: Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157: 238-244, 1978.
14. [14] Mizutani H, Black R, Kupper TS: Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest 87: 1066-1071, 1991.
15. [15] Higgins GC, Foster JL, Postlethwaite AE: Interleukin 1 beta propeptide is detected intracellularly and extracellularly when human monocytes are stimulated with LPS in vitro. J Exp Med 180: 607-14, 1994.
16. [16] Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM: Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 94: 354-62, 1993.
17. [17] Nickoloff BJ, Karabin GD, Barker JN, Griffiths CE, Sarma V, Mitra RS, Elder JT, Kunkel SL, Dixit VM: Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 138: 129-40, 1991.
18. [18] Braun-Falco O, Christphers E: Structural aspects of initial psoriatic lesions. Arch Dermatol Forschung 251: 95-110, 1974.
19. [19] Nickoloff BJ, Fivenson DP, Kunkel SL, Stricter RM, Turka LA. Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques. Clin Imm Immunopath 73: 63-68,1994.
20. [20] Bianchi L, Farrace MG, Nini G, Piacentini M: Abnormal Bcl-2 and 'tissue' transglutaminase expression in psoriatic skin. J Invest Dermatol 103: 829-33, 1994.